Evidence library

The α2A-adrenergic autoreceptor participates in negative-feedback regulation

Genetic and pharmacological studies indicate that α2A is an important presynaptic regulator of norepinephrine transmission, while α2C can also contribute depending on tissue and activity pattern.

Evidence classification. Preclinical evidence. This entry was last reviewed July 16, 2026.

Relevance to Aeviant. This feedback biology provides part of the published rationale for the AVX-1 research question.

Limitations. Key studies use knockout mice and peripheral or ex vivo preparations. They do not establish that α2A is the sole autoreceptor, establish human translation, or provide experimental evidence about AVX-1.

Locus coeruleus autoregulation may not be homogeneous

Projection-defined mouse locus coeruleus neurons have shown differences in somatodendritic α2-autoreceptor function.

Evidence classification. Preclinical evidence. This entry was last reviewed July 16, 2026.

Relevance to Aeviant. The finding cautions against treating one receptor mechanism as physiologically identical across every circuit or tissue context.

Limitations. The work used adult male mouse slices and small projection-defined samples; it is not a clean demonstration of α2A alone and does not establish human relevance.

The locus coeruleus is broadly connected but internally structured

Viral-genetic tracing in mice found broad locus coeruleus inputs and outputs alongside evidence of subcircuit organization.

Evidence classification. Preclinical evidence. This entry was last reviewed July 16, 2026.

Relevance to Aeviant. Distributed noradrenergic anatomy is one reason system-level consequences cannot be inferred from target binding alone.

Limitations. Anatomical tracing in mice does not establish human function, uniform broadcasting, or a therapeutic mechanism.

Locus coeruleus neurons can exhibit transient stimulus responses

Extracellular recordings in behaving rats identified short-latency transient responses to non-noxious environmental stimuli whose magnitude varied with vigilance.

Evidence classification. Preclinical evidence. This entry was last reviewed July 16, 2026.

Relevance to Aeviant. These observations support treating noradrenergic signalling as temporally structured rather than as a single static output.

Limitations. The study is correlational, uses rats, and does not establish a universal account of attention, salience, or therapeutic modulation.

Tonic and phasic activity relate to behavioural context

Nonhuman-primate recordings associated changes in ongoing locus coeruleus activity and transient responses with vigilance and task state.

Evidence classification. Preclinical evidence. This entry was last reviewed July 16, 2026.

Relevance to Aeviant. The literature motivates explicit evaluation of timing and state when interpreting noradrenergic interventions.

Limitations. These are observational and modelling studies. Tonic and phasic activity should not be reduced to a simple pathological-versus-beneficial binary.

Experimental locus coeruleus activation can produce frequency-dependent effects

Optogenetic work in mice demonstrated a causal relationship between imposed locus coeruleus firing patterns and measures of cortical activity and arousal.

Evidence classification. Preclinical evidence. This entry was last reviewed July 16, 2026.

Relevance to Aeviant. The study illustrates that timing and pattern can matter to system-level consequences.

Limitations. Optogenetic stimulation can be nonphysiological. Mouse arousal findings do not establish human efficacy or show that any drug preserves endogenous dynamics.

α2A signalling has measurable time-dependent kinetics

Cell-based FRET measurements described fast, nonequilibrium activation of α2A and downstream Gi by norepinephrine.

Evidence classification. Preclinical evidence. This entry was last reviewed July 16, 2026.

Relevance to Aeviant. The work provides a mechanistic example of why temporal context can matter when receptor pharmacology is evaluated.

Limitations. The study used engineered sensors in living cells rather than native neurons or in vivo physiology and contains no evidence about an α2A PAM or AVX-1.

Positive allosteric modulation is defined relative to a specified orthosteric ligand and context

IUPHAR nomenclature distinguishes orthosteric agonism, allosteric agonism, and positive allosteric modulation, and emphasizes probe, pathway, tissue, and assay dependence.

Evidence classification. Established biology. This entry was last reviewed July 16, 2026.

Relevance to Aeviant. This framework supports the terminology used to describe the AVX-1 program objective.

Limitations. Consensus nomenclature does not validate AVX-1. Ligand dependence, intrinsic activity, subtype selectivity, and signalling behaviour require experimental measurement.

Aeviant’s public interpretation for AVX-1

Aeviant is investigating whether potentiating the α2A response to endogenous norepinephrine can restore an autoinhibitory brake without forcing the receptor on through direct agonism.

Evidence classification. Aeviant interpretation. This entry was last reviewed July 16, 2026.

Relevance to Aeviant. This is the public, thesis-level interpretation that connects published autoreceptor biology to the AVX-1 research program.

Limitations. This is an Aeviant interpretation, not an experimental finding. AVX-1 is a research program, not a physical molecule, and no assay or functional validation has been completed.

No external source is listed because this entry records an Aeviant interpretation or program objective, not a published finding or a reported experimental result.

AVX-1 program objectives

AVX-1 is intended to identify and characterize a small-molecule positive allosteric modulator with endogenous-ligand dependence, low intrinsic agonism, α2A subtype selectivity, and a Gi-biased, arrestin-sparing signalling profile.

Evidence classification. Program objective. This entry was last reviewed July 16, 2026.

Relevance to Aeviant. These objectives state what future experimental work would need to evaluate without presenting any intended property as achieved.

Limitations. No physical molecule has been synthesized and no assay has been run. Endogenous-ligand dependence, low intrinsic agonism, subtype selectivity, signalling bias, CNS activity, and preservation of signalling dynamics are unvalidated objectives.

No external source is listed because this entry records an Aeviant interpretation or program objective, not a published finding or a reported experimental result.